Virologist honoured for his immune system research
Associate Professor David Olagnier from Aarhus University is investigating how the immune system manages cancer and viral infections. He hopes that his work may find a cure for terminally ill patients. Now, he is awarded the ICIS-Regeneron New Investigator Award for Excellence.
Over the past ten years, Associate Professor David Olagnier from the Department of Biomedicine has made a name for himself within viral immunology. He uses a genetically modified virus, an oncolytic virus, as a sort of precision missile to combat – and preferably kill – multi-resistant cancer cells.
David Olagnier is the recipient of this year's ICIS-Regeneron New Investigator Award for Excellence in recognition of his extraordinary contributions to international research on interferons; the group of different soluble factors that act as signalling agents between cells and increase the body's resilience to viral infections.